Written answers
Wednesday, 10 July 2024
Department of Health
Medicinal Products
Robert Troy (Longford-Westmeath, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
283. To ask the Minister for Health if Ireland always complies with EU Directive 89/105/EEC, which states that Member States must make a decision on the price charged and the level of reimbursement for a medicinal product within 90 days of receiving an application, provided all the necessary information is provided. [30119/24]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
John Lahart (Dublin South West, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
284. To ask the Minister for Health the status of the reimbursement of radioligand therapy (RLT) treatments by the HSE; if he will ensure that this treatment is made available to cancer patients immediately once reimbursed; if he is aware that cancer patients were left waiting at least two years to receive one form of RLT after the treatment was reimbursed in 2021 due to the fact that the health service was not equipped to administer the treatment. [30121/24]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
As this is a service matter, I have asked the Health Service Executive to respond to the Deputy as soon as possible.
No comments